Vern Schramm, Ph.D. presents "Transition State Therapeutics: Cancer and Beyond" at the "Bridging the Translational Divides" symposium hosted by the Einstein-Montefiore Institute for Clinical and Translational Research. Dr. Schramm is professor and Ruth Merns Chair of biochemistry at Einstein.

Vern Schramm, Ph.D., on Transition State Therapeutics

The Institute for Clinical and Translational Research (ICTR) held an all-day symposium entitled "Bridging the Translational Divides," which featured presentations and keynote speeches by invited national leaders in translational research and some of the leading faculty at Albert Einstein College of Medicine. The ICTR will re-engineer clinical and translational research, reorganize research facilities, transform training and educational programs, and expand the pool of young investigators.  The ICTR is jointly sponsored by Einstein and Montefiore Medical Center, The University Hospital and Academic Medical Center for Einstein.

Medicine

Education

The Institute for Clinical and Translational Research (ICTR) held an all-day symposium entitled "Bridging the Translational Divides," which featured presentations and keynote speeches by invited national leaders in translational research and some of the leading faculty at Albert Einstein College of Medicine. The ICTR will re-engineer clinical and translational research, reorganize research facilities, transform training and educational programs, and expand the pool of young investigators. The ICTR is jointly sponsored by Einstein and Montefiore Medical Center, The University Hospital and Academic Medical Center for Einstein.

Share Vern Schramm, Ph.D., on Transition State Therapeutics

Sign up to save your podcasts

Vern Schramm, Ph.D., on Transition State Therapeutics

Vern Schramm, Ph.D., on Transition State Therapeutics